Sunshine Biopharma (NASDAQ:SBFM) Issues Quarterly Earnings Results

Sunshine Biopharma (NASDAQ:SBFM) announced its quarterly earnings results on Tuesday. The company reported ($0.94) earnings per share for the quarter, missing the consensus estimate of $9.00 by ($9.94), Zacks reports. The company had revenue of $8.44 million for the quarter. Sunshine Biopharma had a negative return on equity of 16.09% and a negative net margin of 12.07%.

Sunshine Biopharma Trading Up 1.5 %

SBFM traded up $0.04 during midday trading on Thursday, hitting $2.72. 191,163 shares of the company were exchanged, compared to its average volume of 128,353. The company’s 50 day simple moving average is $2.96 and its 200 day simple moving average is $1.65. The firm has a market capitalization of $3.32 million, a price-to-earnings ratio of -0.01 and a beta of 1.38. Sunshine Biopharma has a 1-year low of $2.42 and a 1-year high of $637.20.

About Sunshine Biopharma

Sunshine Biopharma, Inc, a pharmaceutical company, focuses on the research and development of life-saving medicines in various therapeutic areas, including oncology and antivirals in the United States and Canada. It operates in two segments, Prescription Generic Pharmaceuticals and Nonprescription Over-The-Counter Products.